{"denoms":[{"counts":[{"groupId":"BG000","value":"94"},{"groupId":"BG001","value":"94"},{"groupId":"BG002","value":"188"}],"units":"Participants"}],"groups":[{"description":"Participants received a single IV dose of placebo three days before the start of radiotherapy, and then 7 once weekly placebo doses during a 7-week radiotherapy/chemotherapy course.","id":"BG000","title":"Placebo"},{"description":"Participants received a single intravenous dose of palifermin at 180 μg/kg three days before the start of radiotherapy, and then 7 once weekly palifermin doses at the same dose level during a 7-week radiotherapy/chemotherapy course.","id":"BG001","title":"Palifermin"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.3","value":"55.4"},{"groupId":"BG001","spread":"8.6","value":"55.5"},{"groupId":"BG002","spread":"8.5","value":"55.5"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"29"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"80"},{"groupId":"BG001","value":"79"},{"groupId":"BG002","value":"159"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"90"},{"groupId":"BG001","value":"83"},{"groupId":"BG002","value":"173"}]}],"title":"Caucasian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"9"}]}],"title":"Black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"5"}]}],"title":"Hispanic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}],"title":"American Indian/ Alaska Native"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"15.7","value":"71.8"},{"groupId":"BG001","spread":"16.4","value":"74.5"},{"groupId":"BG002","spread":"16.1","value":"73.2"}]}]}],"description":"Data available for 91 and 94 participants in each treatment group respectively.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Weight","unitOfMeasure":"kilograms"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"55"}]}],"title":"Stage III"},{"categories":[{"measurements":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"114"}]}],"title":"Stage IV A"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"19"}]}],"title":"Stage IV B"}],"description":"American Joint Committee on Cancer staging system.","paramType":"NUMBER","title":"Disease Stage","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"14"}]}],"title":"Oral Cavity"},{"categories":[{"measurements":[{"groupId":"BG000","value":"51"},{"groupId":"BG001","value":"55"},{"groupId":"BG002","value":"106"}]}],"title":"Oropharynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"}]}],"title":"Nasopharynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"25"}]}],"title":"Larynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"22"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"36"}]}],"title":"Hypopharynx"}],"paramType":"NUMBER","title":"Tumor Site","unitOfMeasure":"participants"}]}